Richard Austin

Biotech Executive | Cancer Therapeutics | Drug Development Strategist | Life Sciences Investor

📍 United States🔄 Updated October 2026💼 1 investments📅 21 years investing🗓 Last invested Jan 2005
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
21y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Group Leader and Principal Research Investigator-Analytical Chemistry
Jan 2005
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
Experience · 3 entries
All (3)
Investments (1)
Founder (1)
2016
CEO & Co-Founder
Nov 2016
Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.
Commercialization Partner
Jan 2016
Tech Launch Arizona creates real and lasting impact through bringing the inventions of the University of Arizona from the lab to the world. Through its commercialization continuum, TLA transforms University discoveries into intellectual property, new inventions and novel businesses. A Presidential cabinet-level office, TLA embodies the prioritization of the UA’s technology commercialization and industry-sponsored research efforts, moving knowledge and inventions developed by students and faculty into the market. TLA brings together researchers, the business community and the assets of Tech Parks Arizona to significantly enhance the impact of UA research and technological innovation. By 2020, the UA through Tech Launch Arizona aims to become a recognized national resource for its role in integrating UA-created knowledge into solutions for tangible economic and social benefit.
2005
Group Leader and Principal Research Investigator-Analytical Chemistry
Jan 2005
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms